Article info
PDFLetter
Chloroquine and hydroxychloroquine for COVID-19: time to close the chapter
- Correspondence to Amit Malviya, Department of Cardiology, North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences, Mawdiangdiang, Shillong, Meghalaya, India; dramit_malviya{at}rediffmail.com
Citation
Chloroquine and hydroxychloroquine for COVID-19: time to close the chapter
Publication history
- Accepted June 30, 2020
- First published August 11, 2020.
Online issue publication
September 28, 2021
Article Versions
- Previous version (11 August 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ's website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage